Search Login Register

Central Nervous System Cavernous Hemangioma Summary

Description: A vascular anomaly composed of a collection of large, thin walled tortuous VEINS that can occur in any part of the central nervous system but lack intervening nervous tissue. Familial occurrence is common and has been associated with a number of genes mapped to 7q, 7p and 3q. Clinical features include SEIZURES; HEADACHE; STROKE; and progressive neurological deficit.

Also Known As: Hemangioma, Cavernous, Central Nervous System; Cavernous Angioma, Central Nervous System; Cavernous Hemangioma of Brain; Cavernous Hemangioma, Extracerebral; Cavernous Hemangioma, Intracerebral; Brain Cavernous Hemangioma; Brain Cavernous Hemangiomas; Cavernous Hemangioma, Cerebral; Cavernous Hemangiomas, Cerebral; Cavernous Hemangiomas, Extracerebral; Cavernous Hemangiomas, Intracerebral; Cerebral Cavernous Hemangiomas; Extracerebral Cavernous Hemangioma; Extracerebral Cavernous Hemangiomas; Hemangioma, Cerebral Cavernous; Hemangioma, Extracerebral Cavernous; Hemangioma, Intracerebral Cavernous; Hemangiomas, Cerebral Cavernous; Hemangiomas, Extracerebral Cavernous; Hemangiomas, Intracerebral Cavernous; Intracerebral Cavernous Hemangioma; Intracerebral Cavernous Hemangiomas; Cavernous Hemangioma, Central Nervous System; Cerebral Cavernous Hemangioma

Networked: 10 relevant articles (0 outcomes, 0 trials/studies) for this Disease

Key Drugs and Agents for Central Nervous System Cavernous Hemangioma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:

Retinaldehyde (Retinal) : 2 results : IBA
Gadolinium DTPA (Magnevist) : 1 result : FDA 2
Phenytoin (Dilantin) : 1 result : FDA 9 Generic
Insulin (Novolin) : 1 result : FDA 2
Hemosiderin : 1 result : IBA

Diseases Related to Central Nervous System Cavernous Hemangioma

Key Therapies for Central Nervous System Cavernous Hemangioma

Efficacy Chart >>